1. Ceramide synthases in cancer therapy and chemoresistance
   Sebastian Brachtendorf et al, 2019, Progress in Lipid Research CrossRef
2. Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype
   Trishna Pani et al, 2021, Cell Death & Disease CrossRef
3. WITHDRAWN: Ceramide synthases in cancer therapy and chemoresistance
   Sebastian Brachtendorf et al, 2019, Progress in Lipid Research CrossRef
4. Overexpression of LASS2 inhibits proliferation and causes G0/G1 cell cycle arrest in papillary thyroid cancer
   Feng Zeng et al, 2018, Cancer Cell International CrossRef
5. ASR488, a novel small molecule, activates an mRNA binding protein, CPEB1, and inhibits the growth of bladder cancer
   Ashish Tyagi et al, 2020, Oncology Letters CrossRef
6. LASS2 overexpression enhances early apoptosis of lung cancer cells through the caspase‑dependent pathway
   Yamei Wang et al, 2022, Oncology Reports CrossRef
7. Clinical and pathological significance of Homo sapiens ceramide synthase 2 (CerS-2) in diverse human cancers
   Qian Zhang et al, 2019, Bioscience Reports CrossRef
8. The Role of Longevity Assurance Homolog 2/Ceramide Synthase 2 in Bladder Cancer
   Clara Garcia-Vallicrosa et al, 2023, International Journal of Molecular Sciences CrossRef
9. Identify Potential Urine Biomarkers for Bladder Cancer Prognosis Using NGS Data Analysis and Experimental Validation
   Ruimin Ren et al, 2023, Applied Biochemistry and Biotechnology CrossRef
10. How miRNAs Regulate Schwann Cells during Peripheral Nerve Regeneration—A Systemic Review
    Anton Borger et al, 2022, International Journal of Molecular Sciences CrossRef
11. Impact of cancer metabolism on therapy resistance – Clinical implications
    Ana Cristina Gonçalves et al, 2021, Drug Resistance Updates CrossRef
12. miR-3622a promotes proliferation and invasion of bladder cancer cells by downregulating LASS2
    Shi Fu et al, 2019, Gene CrossRef
13. LASS2 suppresses metastasis in multiple cancers by regulating the ferroptosis signalling pathway through interaction with TFRC
    Yunfei Huang et al, 2024, Cancer Cell International CrossRef
14. Evaluation of CERS2 Gene as a Potential Biomarker for Bladder Cancer
    Ahmed Faris Aldoghachi et al, 2019, Disease Markers CrossRef
15. High expression of LASS2 is associated with unfavorable prognosis in patients with ovarian cancer
    Ning Sheng et al, 2019, Journal of Cellular Physiology CrossRef
16. Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets
    Joanna Kopecka et al, 2020, Drug Resistance Updates CrossRef
17. Association of rs8444 polymorphism in the LASS2 3′-UTR and bladder cancer risk in Chinese population
    Yinglong Huang et al, 2020, European Journal of Cancer Prevention CrossRef